hydroxychloroquine has been researched along with Pulsatile Tinnitus in 4 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The suggested dose of chloroquine for COVID-19 infection is considerably higher than the usual dosage for malaria treatment; therefore, it is plausible that the ototoxic effects will be greater." | 6.66 | Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review. ( Baguley, DM; Kasbekar, AV; Prayuenyong, P, 2020) |
| " The suggested dose of chloroquine for COVID-19 infection is considerably higher than the usual dosage for malaria treatment; therefore, it is plausible that the ototoxic effects will be greater." | 2.66 | Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review. ( Baguley, DM; Kasbekar, AV; Prayuenyong, P, 2020) |
| "Hydroxychloroquine is an oral antimalarial medication commonly used off-label for a variety of rheumatological conditions, including systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome and dermatomyositis." | 1.46 | Accidental hydroxychloroquine overdose resulting in neurotoxic vestibulopathy. ( Chansky, PB; Werth, VP, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prayuenyong, P | 1 |
| Kasbekar, AV | 1 |
| Baguley, DM | 1 |
| Saniasiaya, J | 1 |
| Kulasegarah, J | 1 |
| Chansky, PB | 1 |
| Werth, VP | 1 |
| Fernandes, MRN | 1 |
| Soares, DBR | 1 |
| Thien, CI | 1 |
| Carneiro, S | 1 |
1 review available for hydroxychloroquine and Pulsatile Tinnitus
| Article | Year |
|---|---|
Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review.
Topics: Antimalarials; Antiviral Agents; Chloroquine; COVID-19 Drug Treatment; Emergencies; Hearing Loss; Hu | 2020 |
3 other studies available for hydroxychloroquine and Pulsatile Tinnitus
| Article | Year |
|---|---|
Auditory Cinchonism in COVID Era.
Topics: Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Tre | 2020 |
Accidental hydroxychloroquine overdose resulting in neurotoxic vestibulopathy.
Topics: Ataxia; Drug Overdose; Female; Humans; Hydroxychloroquine; Middle Aged; Paresthesia; Tinnitus; Visio | 2017 |
Hydroxychloroquine ototoxicity in a patient with systemic lupus erythematosus.
Topics: Antimalarials; Antirheumatic Agents; Arthritis; Female; Hearing Loss, Sensorineural; Humans; Hydroxy | 2018 |